| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |